1. Perry J R B, Murray A, Day F R. Molecular insights into the aetiology of female reproductive ageing. Nat Rev Endocrinol, 2015, 11: 725-734.
2. Menopause Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. The 2023 Chinese menopause symptom management and menopausal hormone therapy guidelines (in Chinese). Chin J Obstet Gynecol, 2023, 58: 4–21 [中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版. 中华妇产科杂志, 2023, 58: 4–21].
3. Chen R. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines (in Chinese). Med J Peking Union Med Coll Hosp, 2023, 14: 514–519 [陈蓉. 《中国绝经管理与绝经激素治疗指南2023版》解读. 协和医学杂志, 2023, 14: 514–519].
4. Ding X, Lv S, Guo Z. Potential therapeutic options for premature ovarian insufficiency: experimental and clinical evidence. Reprod Sci, 2023, 30: 3428-3442.
5. Golezar S, Ramezani Tehrani F, Khazaei S. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric, 2019, 22: 403-411.